HC asks govts. reason for scarcity of Remdesivir drug in Capital
The Hindu
It was hearing plea by a lawyer who is infected
The Delhi High Court on Tuesday asked the Centre and city government on the reason behind the scarcity of Remdesivir drug in the Capital when the medication was being widely prescribed for COVID-19 patients. Justice Prathiba M. Singh said several companies in India were manufacturing the medicine and millions of vials of the drug must have been exported, “but we do not have enough to cater to our own patients”.More Related News
One dies, eight hospitalised after inhaling HCL fumes at pharma company in Andhra Pradesh’s Anakapalli district. About 400 litres of HCL leaked from the reactor-cum-receiver tank at Unit-III of the company, which affected nine workers, says Collector. While the condition of six of them is stable, two are on ventilator support. Chief Minister Chandrababu Naidu directs authorities to provide advanced treatment to the victims. Home Minister Anitha expresses anger over repeated such incidents.